Canaccord analyst Kyle Rose upgraded Koru Medical to Buy from Hold with a price target of $4, up from $3.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on KRMD:
Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
